Biosimilars in inflammatory bowel disease

被引：2
|
作者：
Moore, Gregory T. [1 ,2 ]
机构：
[1] Monash Hlth, Clayton, Vic, Australia
[2] Monash Univ, Clayton, Vic, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2016年 / 205卷 / 07期
关键词：
D O I：
10.5694/mja16.00775
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：294 / 295
页数：2
相关论文
共 50 条
  • [31] Patient Perceptions Regarding the Use of Biosimilars in Inflammatory Bowel Disease
    Pineles, David
    Arsuaga, Amy
    Malter, Lisa B.
    Bosworth, Brian P.
    Hudesman, David P.
    Chang, Shannon
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S418 - S419
  • [32] Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
    Al Sulais, Eman
    AlAmeel, Turki
    BIOLOGICS-TARGETS & THERAPY, 2020, 14 : 1 - 11
  • [33] Adalimumab originator and biosimilars in global inflammatory bowel disease treatment
    Yiu, Tsz Hong
    Nakase, Hiroshi
    Leung, Wai Keung
    Lin, Huiyu
    Banerjee, Rupa
    Anderson, Emilia
    Leong, Rupert
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 173 - 174
  • [34] BIOSIMILARS SLOW TO GAIN TRACTION FOR INFLAMMATORY BOWEL DISEASE IN THE US
    Zweig, Steven J.
    BIOTECHNOLOGY LAW REPORT, 2020, 39 (03) : 163 - 163
  • [35] Biosimilars in the therapy of inflammatory bowel diseases
    Hlavaty, Tibor
    Letkovsky, Juraj
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (06) : 581 - 587
  • [36] Overview of Biosimilars in Inflammatory Bowel Diseases
    Feagins, Linda A.
    Gold, Stephanie
    Steinlauf, Adam F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (02): : 229 - 232
  • [37] Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients
    Hala Najeeb
    Farah Yasmin
    Salim Surani
    World Journal of Clinical Cases, 2022, (14) : 4327 - 4333
  • [38] Biosimilars in inflammatory bowel disease: A review of post-marketing experience
    Deiana, Simona
    Gabbani, Tommaso
    Annese, Vito
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (02) : 197 - 203
  • [39] Benefits of Biosimilars in the Management of Patients with Inflammatory Bowel Disease: An International Survey
    D'Amico, Ferdinando
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [40] USE OF BIOSIMILARS TO INFLIXIMAB DURING PREGNANCY IN WOMEN WITH INFLAMMATORY BOWEL DISEASE
    Long, Millie D.
    Kane, Sunanda V.
    Beaulieu, Dawn
    Abraham, Bincy P.
    Zhang, Xian
    Mahadevan, Uma
    GASTROENTEROLOGY, 2024, 166 (05) : S1153 - S1154
12345